Proteome of brain glia: The molecular basis of diverse glial phenotypes

Proteomics

Volumn 14, Issue 4-5, 2014, Pages 378-398

  Jha, Mithilesh Kumar ^a   Kim, Jae Hong ^a   Suk, Kyoungho ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Biomarker; Biomedicine; CNS; Glia; Proteome; Therapeutic target

Indexed keywords

BIOLOGICAL MARKER; PROTEOME; AMYLOID; BRAIN DERIVED NEUROTROPHIC FACTOR; CD11B ANTIGEN; CD45 ANTIGEN; CILIARY NEUROTROPHIC FACTOR; CXCL1 CHEMOKINE; EOTAXIN; EOTAXIN 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

BRAIN; BRAIN FUNCTION; BRAIN NERVE CELL; CELL COMMUNICATION; CELL FUNCTION; CELL INTERACTION; CELL METABOLISM; CELL STRUCTURE; CELLULAR SECRETION; CENTRAL NERVOUS SYSTEM; GLIA CELL; GLIOSIS; HUMAN; NERVE CELL LESION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; APOPTOSIS; ASTROCYTE; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM DISEASE; MACROGLIA; MICROGLIA; NEUROTOXICITY; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PHAGOCYTOSIS;

BIOMARKER; BIOMEDICINE; CNS; GLIA; PROTEOME; THERAPEUTIC TARGET;

BRAIN; HUMANS; NEUROGLIA; NEURONS; PHENOTYPE; PROTEOME;

EID: 84896780176     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300236     Document Type: Review

References (272)

1. Barres, B. A., The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 2008, 60, 430-440.
2. Araque, A., Parpura, V., Sanzgiri, R. P., Haydon, P. G., Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 1999, 22, 208-215.
3. Davies, S. J., Shih, C. H., Noble, M., Mayer-Proschel, M. et al., Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury. PLoS One 2011, 6, e17328.
4. Fiacco, T. A., Agulhon, C., McCarthy, K. D., Sorting out astrocyte physiology from pharmacology. Annu. Rev. Pharmacol. Toxicol. 2009, 49, 151-174.
5. Volterra, A., Meldolesi, J., Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 2005, 6, 626-640.
6. Fields, R. D., Stevens-Graham, B., New insights into neuron-glia communication. Science 2002, 298, 556-562.
7. Holley, J. E., Gveric, D., Whatmore, J. L., Gutowski, N. J., Tenascin C induces a quiescent phenotype in cultured adult human astrocytes. Glia 2005, 52, 53-58.
8. Sofroniew, M. V., Vinters, H. V., Astrocytes: biology and pathology. Acta Neuropathol. 2010, 119, 7-35.
9. Yang, C., Rahimpour, S., Yu, A. C., Lonser, R. R., Zhuang, Z., Regulation and dysregulation of astrocyte activation and implications in tumor formation. Cell. Mol. Life Sci. 2013, doi: 10.1007/s00018-013-1274-8.
10. East, E., Golding, J. P., Phillips, J. B., A versatile 3D culture model facilitates monitoring of astrocytes undergoing reactive gliosis. J. Tissue Eng. Regen. Med. 2009, 3, 634-646.
11. Nash, B., Ioannidou, K., Barnett, S. C., Astrocyte phenotypes and their relationship to myelination. J. Anat. 2011, 219, 44-52.
12. Martins-de-Souza, D., Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia. J. Psychiatr. Res. 2010, 44, 149-156.
13. Szuchet, S., Nielsen, J. A., Lovas, G., Domowicz, M. S. et al., The genetic signature of perineuronal oligodendrocytes reveals their unique phenotype. Eur. J. Neurosci. 2011, 34, 1906-1922.
14. Kaur, C., Hao, A. J., Wu, C. H., Ling, E. A., Origin of microglia. Microsc. Res. Tech. 2001, 54, 2-9.
15. Aloisi, F., Immune function of microglia. Glia 2001, 36, 165-179.
16. Lull, M. E., Block, M. L., Microglial activation and chronic neurodegeneration. Neurotherapeutics 2010, 7, 354-365.
17. Varnum, M. M., Ikezu, T., The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain. Arch. Immunol. Ther. Exp. (Warsz) 2012, 60, 251-266.
18. Perry, V. H., Nicoll, J. A., Holmes, C., Microglia in neurodegenerative disease. Nat. Rev. Neurol. 2010, 6, 193-201.
19. Jha, M. K., Suk, K., Glia-based biomarkers and their functional role in the CNS. Expert Rev. Proteomics 2013, 10, 43-63.
20. Jha, M. K., Seo, M., Kim, J. H., Kim, B. G. et al., The secretome signature of reactive glial cells and its pathological implications. Biochim. Biophys. Acta 2012, 1834, 2418-2428.
21. Denis-Donini, S., Glowinski, J., Prochiantz, A., Glial heterogeneity may define the three-dimensional shape of mouse mesencephalic dopaminergic neurones. Nature 1984, 307, 641-643.
22. Lawson, L. J., Perry, V. H., Dri, P., Gordon, S., Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990, 39, 151-170.
23. Kettenmann, H., Hanisch, U. K., Noda, M., Verkhratsky, A., Physiology of microglia. Physiol. Rev. 2011, 91, 461-553.
24. Hanisch, U. K., Functional diversity of microglia: how heterogeneous are they to begin with? Front Cell. Neurosci. 2013, 7, 65.
25. Meeuwsen, S., Bsibsi, M., Persoon-Deen, C., Ravid, R., van Noort, J. M., Cultured human adult microglia from different donors display stable cytokine, chemokine and growth factor gene profiles but respond differently to a pro-inflammatory stimulus. Neuroimmunomodulation 2005, 12, 235-245.
26. Sierra, A., Gottfried-Blackmore, A. C., McEwen, B. S., Bulloch, K., Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 2007, 55, 412-424.
27. Hewett, J. A., Determinants of regional and local diversity within the astroglial lineage of the normal central nervous system. J. Neurochem. 2009, 110, 1717-1736.
28. Daniel-Christoph, W., Scheibe, J., Glocke, I., Weise, G. et al., Object-based analysis of astroglial reaction and astrocyte subtype morphology after ischemic brain injury. Acta. Neurobiol. Exp. (Wars) 2013, 73, 79-87.
29. Bardehle, S., Kruger, M., Buggenthin, F., Schwausch, J. et al., Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation. Nat. Neurosci. 2013, 16, 580-586.
30. Mansour, H., McColm, J. R., Cole, L., Weible, M., 2nd et al., Connexin 30 expression and frequency of connexin heterogeneity in astrocyte gap junction plaques increase with age in the rat retina. PLoS One 2013, 8, e57038.
31. Theis, M., Giaume, C., Connexin-based intercellular communication and astrocyte heterogeneity. Brain Res. 2012, 1487, 88-98.
32. Zhang, Y., Barres, B. A., Astrocyte heterogeneity: an underappreciated topic in neurobiology. Curr. Opin. Neurobiol. 2010, 20, 588-594.
33. Matyash, V., Kettenmann, H., Heterogeneity in astrocyte morphology and physiology. Brain Res. Rev. 2010, 63, 2-10.
34. Chaboub, L. S., Deneen, B., Developmental origins of astrocyte heterogeneity: the final frontier of CNS development. Dev. Neurosci. 2012, 34, 379-388.
35. Wasinger, V. C., Cordwell, S. J., Cerpa-Poljak, A., Yan, J. X. et al., Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 1995, 16, 1090-1094.
36. Abbott, A., And now for the proteome. Nature 2001, 409, 747.
37. Severino, V., Farina, A., Chambery, A., Analysis of secreted proteins. Methods Mol. Biol. 2013, 1002, 37-60.
38. Kim, J. H., Seo, M., Suk, K., Effects of therapeutic hypothermia on the glial proteome and phenotype. Curr. Protein Pept. Sci. 2013, 14, 51-60.
39. Zamanian, J. L., Xu, L., Foo, L. C., Nouri, N. et al., Genomic analysis of reactive astrogliosis. J. Neurosci. 2012, 32, 6391-6410.
40. Suh, H. S., Zhao, M. L., Derico, L., Choi, N., Lee, S. C., Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators. J. Neuroinflammation 2013, 10, 37.
41. Streit, W. J., Walter, S. A., Pennell, N. A., Reactive microgliosis. Prog. Neurobiol. 1999, 57, 563-581.
42. Zhang, D., Hu, X., Qian, L., O'Callaghan, J. P., Hong, J. S., Astrogliosis in CNS pathologies: is there a role for microglia? Mol. Neurobiol. 2010, 41, 232-241.
43. Verkhratsky, A., Olabarria, M., Noristani, H. N., Yeh, C. Y., Rodriguez, J. J., Astrocytes in Alzheimer's disease. Neurotherapeutics 2010, 7, 399-412.
44. Sofroniew, M. V., Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009, 32, 638-647.
45. Alilain, W. J., Horn, K. P., Hu, H., Dick, T. E., Silver, J., Functional regeneration of respiratory pathways after spinal cord injury. Nature 2011, 475, 196-200.
46. Napoli, I., Neumann, H., Microglial clearance function in health and disease. Neuroscience 2009, 158, 1030-1038.
47. Neumann, H., Kotter, M. R., Franklin, R. J., Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009, 132, 288-295.
48. Farfara, D., Lifshitz, V., Frenkel, D., Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease. J. Cell. Mol. Med. 2008, 12, 762-780.
49. Batchelor, P. E., Porritt, M. J., Martinello, P., Parish, C. L. et al., Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge. Mol. Cell. Neurosci. 2002, 21, 436-453.
50. Zhong, Y., Zhou, L. J., Ren, W. J., Xin, W. J. et al., The direction of synaptic plasticity mediated by C-fibers in spinal dorsal horn is decided by Src-family kinases in microglia: the role of tumor necrosis factor-alpha. Brain Behav. Immun. 2010, 24, 874-880.
51. Davalos, D., Grutzendler, J., Yang, G., Kim, J. V. et al., ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005, 8, 752-758.
52. Tremblay, M. E., Stevens, B., Sierra, A., Wake, H. et al., The role of microglia in the healthy brain. J. Neurosci. 2011, 31, 16064-16069.
53. Trapp, B. D., Wujek, J. R., Criste, G. A., Jalabi, W. et al., Evidence for synaptic stripping by cortical microglia. Glia 2007, 55, 360-368.
54. Yamada, J., Hayashi, Y., Jinno, S., Wu, Z. et al., Reduced synaptic activity precedes synaptic stripping in vagal motoneurons after axotomy. Glia 2008, 56, 1448-1462.
55. Graeber, M. B., Streit, W. J., Microglia: biology and pathology. Acta Neuropathol. 2010, 119, 89-105.
56. Block, M. L., Hong, J. S., Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem. Soc. Trans. 2007, 35, 1127-1132.
57. Block, M. L., Hong, J. S., Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 2005, 76, 77-98.
58. Ransohoff, R. M., Perry, V. H., Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 2009, 27, 119-145.
59. Li, E., Noda, M., Doi, Y., Parajuli, B. et al., The neuroprotective effects of milk fat globule-EGF factor 8 against oligomeric amyloid beta toxicity. J. Neuroinflammation 2012, 9, 148.
60. Moore, C. S., Abdullah, S. L., Brown, A., Arulpragasam, A., Crocker, S. J., How factors secreted from astrocytes impact myelin repair. J. Neurosci. Res. 2011, 89, 13-21.
61. Freeman, M. R., Glial control of synaptogenesis. Cell 2005, 120, 292-293.
62. Yang, J. W., Rodrigo, R., Felipo, V., Lubec, G., Proteome analysis of primary neurons and astrocytes from rat cerebellum. J. Proteome Res. 2005, 4, 768-788.
63. Yang, J. W., Suder, P., Silberring, J., Lubec, G., Proteome analysis of mouse primary astrocytes. Neurochem. Int. 2005, 47, 159-172.
64. Christopherson, K. S., Ullian, E. M., Stokes, C. C., Mullowney, C. E. et al., Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 2005, 120, 421-433.
65. Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C. et al., A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 2008, 28, 264-278.
66. Risher, W. C., Eroglu, C., Thrombospondins as key regulators of synaptogenesis in the central nervous system. Matrix Biol. 2012, 31, 170-177.
67. Eroglu, C., The role of astrocyte-secreted matricellular proteins in central nervous system development and function. J. Cell. Commun. Signal. 2009, 3, 167-176.
68. Tian, W., Sawyer, A., Kocaoglu, F. B., Kyriakides, T. R., Astrocyte-derived thrombospondin-2 is critical for the repair of the blood-brain barrier. Am. J. Pathol. 2011, 179, 860-868.
69. Hayashi, H., Lipid metabolism and glial lipoproteins in the central nervous system. Biol. Pharm. Bull. 2011, 34, 453-461.
70. Min, K. J., Yang, M. S., Kim, S. U., Jou, I., Joe, E. H., Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation. J. Neurosci. 2006, 26, 1880-1887.
71. Yang, M. S., Min, K. J., Joe, E., Multiple mechanisms that prevent excessive brain inflammation. J. Neurosci. Res. 2007, 85, 2298-2305.
72. Rocha, S. M., Cristovao, A. C., Campos, F. L., Fonseca, C. P., Baltazar, G., Astrocyte-derived GDNF is a potent inhibitor of microglial activation. Neurobiol. Dis. 2012, 47, 407-415.
73. Kim, J. H., Cho, Y. E., Seo, M., Baek, M. C., Suk, K., Glial proteome changes in response to moderate hypothermia. Proteomics 2012, 12, 2571-2583.
74. Seo, M., Kim, J. H., Cho, Y. E., Baek, M. C., Suk, K., Hypothermic regulation of astrocyte proteome profile in experimental stroke. Electrophoresis 2012, 33, 3835-3848.
75. Kim, J. H., Seo, M., Han, H. S., Park, J., Suk, K., The neurovascular protection afforded by delayed local hypothermia after transient middle cerebral artery occlusion. Curr. Neurovasc. Res. 2013, 10, 134-143.
76. Zgavc, T., Ceulemans, A. G., Hachimi-Idrissi, S., Kooijman, R. et al., The neuroprotective effect of post ischemic brief mild hypothermic treatment correlates with apoptosis, but not with gliosis in endothelin-1 treated rats. BMC Neurosci. 2012, 13, 105.
77. Diestel, A., Troeller, S., Billecke, N., Sauer, I. M. et al., Mechanisms of hypothermia-induced cell protection mediated by microglial cells in vitro. Eur. J. Neurosci. 2010, 31, 779-787.
78. Shintani, Y., Terao, Y., Ohta, H., Molecular mechanisms underlying hypothermia-induced neuroprotection. Stroke Res. Treat. 2010, 2011, 809-874.
79. Ceulemans, A. G., Zgavc, T., Kooijman, R., Hachimi-Idrissi, S. et al., The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J. Neuroinflammation 2010, 7, 74.
80. Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K. et al., Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 2003, 9, 589-595.
81. Glavaski-Joksimovic, A., Virag, T., Mangatu, T. A., McGrogan, M. et al., Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease. J. Neurosci. Res. 2010, 88, 2669-2681.
82. Uzdensky, A., Komandirov, M., Fedorenko, G., Lobanov, A., Protection effect of GDNF and neurturin on photosensitized crayfish neurons and glial cells. J. Mol. Neurosci. 2013, 49, 480-490.
83. Park, C. K., Ju, W. K., Hofmann, H. D., Kirsch, M. et al., Differential regulation of ciliary neurotrophic factor and its receptor in the rat hippocampus following transient global ischemia. Brain Res. 2000, 861, 345-353.
84. Kang, S. S., Keasey, M. P., Cai, J., Hagg, T., Loss of neuron-astroglial interaction rapidly induces protective CNTF expression after stroke in mice. J. Neurosci. 2012, 32, 9277-9287.
85. Butovsky, O., Talpalar, A. E., Ben-Yaakov, K., Schwartz, M., Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol. Cell. Neurosci. 2005, 29, 381-393.
86. Ziebell, J. M., Taylor, S. E., Cao, T., Harrison, J. L., Lifshitz, J., Rod microglia: elongation, alignment, and coupling to form trains across the somatosensory cortex after experimental diffuse brain injury. J. Neuroinflammation 2012, 9, 247.
87. Ridet, J. L., Malhotra, S. K., Privat, A., Gage, F. H., Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 1997, 20, 570-577.
88. Bush, T. G., Puvanachandra, N., Horner, C. H., Polito, A. et al., Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 1999, 23, 297-308.
89. Rossi, D. J., Brady, J. D., Mohr, C., Astrocyte metabolism and signaling during brain ischemia. Nat. Neurosci. 2007, 10, 1377-1386.
90. Li, L., Lundkvist, A., Andersson, D., Wilhelmsson, U. et al., Protective role of reactive astrocytes in brain ischemia. J. Cereb. Blood Flow Metab. 2008, 28, 468-481.
91. Maragakis, N. J., Rothstein, J. D., Mechanisms of disease: astrocytes in neurodegenerative disease. Nat. Clin. Pract. Neurol. 2006, 2, 679-689.
92. Barres, B. A., Barde, Y., Neuronal and glial cell biology. Curr. Opin. Neurobiol. 2000, 10, 642-648.
93. Farina, C., Aloisi, F., Meinl, E., Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007, 28, 138-145.
94. Zhou, Y., Wang, Y., Kovacs, M., Jin, J., Zhang, J., Microglial activation induced by neurodegeneration: a proteomic analysis. Mol. Cell. Proteomics 2005, 4, 1471-1479.
95. Glanzer, J. G., Enose, Y., Wang, T., Kadiu, I. et al., Genomic and proteomic microglial profiling: pathways for neuroprotective inflammatory responses following nerve fragment clearance and activation. J. Neurochem. 2007, 102, 627-645.
96. Byun, K., Young Kim, J., Bayarsaikhan, E., Kim, D. et al., Quantitative proteomic analysis reveals that lipopolysaccharide induces mitogen-activated protein kinase-dependent activation in human microglial cells. Electrophoresis 2012, 33, 3756-3763.
97. Mosher, K. I., Andres, R. H., Fukuhara, T., Bieri, G. et al., Neural progenitor cells regulate microglia functions and activity. Nat. Neurosci. 2012, 15, 1485-1487.
98. Mahesula, S., Raphael, I., Raghunathan, R., Kalsaria, K. et al., Immunoenrichment microwave and magnetic proteomics for quantifying CD47 in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Electrophoresis 2012, 33, 3820-3829.
99. Dutta, G., Barber, D. S., Zhang, P., Doperalski, N. J., Liu, B., Involvement of dopaminergic neuronal cystatin C in neuronal injury-induced microglial activation and neurotoxicity. J. Neurochem. 2012, 122, 752-763.
100. Abere, B., Wikan, N., Ubol, S., Auewarakul, P. et al., Proteomic analysis of chikungunya virus infected microgial cells. PLoS One 2012, 7, e34800.
101. Liu, B., Barber, D. S., Stevens, S. M., Jr., Stable isotope labeling with amino acids in cell culture-based proteomic analysis of ethanol-induced protein expression profiles in microglia. Methods Mol. Biol. 2012, 829, 551-565.
102. Jeon, H., Lee, S., Lee, W. H., Suk, K., Analysis of glial secretome: the long pentraxin PTX3 modulates phagocytic activity of microglia. J. Neuroimmunol. 2010, 229, 63-72.
103. Singh, A. K., Tiwari, M. N., Dixit, A., Upadhyay, G. et al., Nigrostriatal proteomics of cypermethrin-induced dopaminergic neurodegeneration: microglial activation-dependent and -independent regulations. Toxicol. Sci. 2011, 122, 526-538.
104. Huang, X., Stone, D. K., Yu, F., Zeng, Y., Gendelman, H. E., Functional proteomic analysis for regulatory T cell surveillance of the HIV-1-infected macrophage. J. Proteome Res. 2010, 9, 6759-6773.
105. Reynolds, A. D., Glanzer, J. G., Kadiu, I., Ricardo-Dukelow, M. et al., Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease. J. Neurochem. 2008, 104, 1504-1525.
106. Junker, H., Suofu, Y., Venz, S., Sascau, M. et al., Proteomic identification of an upregulated isoform of annexin A3 in the rat brain following reversible cerebral ischemia. Glia 2007, 55, 1630-1637.
107. Di Francesco, L., Correani, V., Fabrizi, C., Fumagalli, L. et al., 14-3-3epsilon marks the amyloid-stimulated microglia long-term activation. Proteomics 2012, 12, 124-134.
108. Rock, R. B., Gekker, G., Hu, S., Sheng, W. S. et al., Role of microglia in central nervous system infections. Clin. Microbiol. Rev. 2004, 17, 942-964.
109. Liu, B., Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease. AAPS J. 2006, 8, E606-E621.
110. Bell-Temin, H., Barber, D. S., Zhang, P., Liu, B., Stevens, S. M., Jr., Proteomic analysis of rat microglia establishes a high-confidence reference data set of over 3000 proteins. Proteomics 2012, 12, 246-250.
111. Hyakkoku, K., Hamanaka, J., Tsuruma, K., Shimazawa, M., Hara, H., Proteomic approach with LCMS-IT-TOF identified an increase of Rab33B after transient focal cerebral ischemia in mice. Exp. Transl. Stroke Med. 2010, 2, 20.
112. Gadea, A., Schinelli, S., Gallo, V., Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway. J. Neurosci. 2008, 28, 2394-2408.
113. Ji, R. R., Gereau, R. W. t., Malcangio, M., Strichartz, G. R., MAP kinase and pain. Brain Res. Rev. 2009, 60, 135-148.
114. Ito, N., Obata, H., Saito, S., Spinal microglial expression and mechanical hypersensitivity in a postoperative pain model: comparison with a neuropathic pain model. Anesthesiology 2009, 111, 640-648.
115. Obata, H., Eisenach, J. C., Hussain, H., Bynum, T., Vincler, M., Spinal glial activation contributes to postoperative mechanical hypersensitivity in the rat. J. Pain 2006, 7, 816-822.
116. McMahon, S. B., Malcangio, M., Current challenges in glia-pain biology. Neuron 2009, 64, 46-54.
117. Mika, J., Korostynski, M., Kaminska, D., Wawrzczak-Bargiela, A. et al., Interleukin-1 alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model. Pain 2008, 138, 587-597.
118. Mika, J., Rojewska, E., Makuch, W., Przewlocka, B., Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain. Neuroscience 2010, 165, 1420-1428.
119. Mika, J., Wawrzczak-Bargiela, A., Osikowicz, M., Makuch, W., Przewlocka, B., Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice. Brain Behav. Immun. 2009, 23, 75-84.
120. Mika, J., Obara, I., Przewlocka, B., The role of nociceptin and dynorphin in chronic pain: implications of neuro-glial interaction. Neuropeptides 2011, 45, 247-261.
121. Mika, J., Zychowska, M., Popiolek-Barczyk, K., Rojewska, E., Przewlocka, B., Importance of glial activation in neuropathic pain. Eur. J. Pharmacol. 2013, 716, 106-119.
122. DeLeo, J. A., Tanga, F. Y., Tawfik, V. L., Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist 2004, 10, 40-52.
123. Marchand, F., Perretti, M., McMahon, S. B., Role of the immune system in chronic pain. Nat. Rev. Neurosci. 2005, 6, 521-532.
124. Watkins, L. R., Hutchinson, M. R., Milligan, E. D., Maier, S. F., "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids. Brain Res. Rev. 2007, 56, 148-169.
125. Piao, Z. G., Cho, I. H., Park, C. K., Hong, J. P. et al., Activation of glia and microglial p38 MAPK in medullary dorsal horn contributes to tactile hypersensitivity following trigeminal sensory nerve injury. Pain 2006, 121, 219-231.
126. Guo, W., Wang, H., Watanabe, M., Shimizu, K. et al., Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J. Neurosci. 2007, 27, 6006-6018.
127. Ren, K., Dubner, R., Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr. Opin. Anaesthesiol. 2008, 21, 570-579.
128. Jeon, S., Jha, M. K., Ock, J., Seo, J. et al., Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury. J. Biol. Chem. 2013, 288, 24116-24127.
129. Inoue, K., Tsuda, M., Microglia and neuropathic pain. Glia 2009, 57, 1469-1479.
130. Masuda, T., Tsuda, M., Yoshinaga, R., Tozaki-Saitoh, H. et al., IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype. Cell Rep. 2012, 1, 334-340.
131. Tsuda, M., Mizokoshi, A., Shigemoto-Mogami, Y., Koizumi, S., Inoue, K., Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 2004, 45, 89-95.
132. Lim, H., Kim, D., Lee, S. J., Toll-like receptor 2 mediates peripheral nerve injury-induced NADPH oxidase 2 expression in spinal cord microglia. J. Biol. Chem. 2013, 288, 7572-7579.
133. Tan, Y. H., Li, K., Chen, X. Y., Cao, Y. et al., Activation of Src family kinases in spinal microglia contributes to formalin-induced persistent pain state through p38 pathway. J. Pain 2012, 13, 1008-1015.
134. Simonetti, M., Hagenston, A. M., Vardeh, D., Freitag, H. E. et al., Nuclear calcium signaling in spinal neurons drives a genomic program required for persistent inflammatory pain. Neuron 2013, 77, 43-57.
135. Echeverry, S., Shi, X. Q., Zhang, J., Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain. Pain 2008, 135, 37-47.
136. Watkins, L. R., Milligan, E. D., Maier, S. F., Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv. Exp. Med. Biol. 2003, 521, 1-21.
137. Jha, M. K., Jeon, S., Suk, K., Glia as a link between neuroinflammation and neuropathic pain. Immune Netw. 2012, 12, 41-47.
138. Chen, G., Tanabe, K., Yanagidate, F., Kawasaki, Y. et al., Intrathecal endothelin-1 has antinociceptive effects in rat model of postoperative pain. Eur. J. Pharmacol. 2012, 697, 40-46.
139. Hung, V. K., Chen, S. M., Tai, L. W., Chen, A. Y. et al., Over-expression of endothelin-1 in astrocytes, but not endothelial cells, ameliorates inflammatory pain response after formalin injection. Life Sci. 2012, 91, 618-622.
140. Tonari, M., Kurimoto, T., Horie, T., Sugiyama, T. et al., Blocking endothelin-B receptors rescues retinal ganglion cells from optic nerve injury through suppression of neuroinflammation. Invest. Ophthalmol. Vis. Sci. 2012, 53, 3490-3500.
141. Vincent, A. J., Lau, P. W., Roskams, A. J., SPARC is expressed by macroglia and microglia in the developing and mature nervous system. Dev. Dyn. 2008, 237, 1449-1462.
142. Lloyd-Burton, S. M., York, E. M., Anwar, M. A., Vincent, A. J., Roskams, A. J., SPARC regulates microgliosis and functional recovery following cortical ischemia. J. Neurosci. 2013, 33, 4468-4481.
143. Bi, F., Huang, C., Tong, J., Qiu, G. et al., Reactive astrocytes secrete lcn2 to promote neuron death. Proc. Natl. Acad. Sci. U S A 2013, 110, 4069-4074.
144. Jang, E., Lee, S., Kim, J. H., Seo, J. W. et al., Secreted protein lipocalin-2 promotes microglial M1 polarization. FASEB J. 2013, 27, 1176-1190.
145. Berard, J. L., Zarruk, J. G., Arbour, N., Prat, A. et al., Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Glia 2012, 60, 1145-1159.
146. Kim, H., Lee, S., Park, H. C., Lee, W. H. et al., Modulation of glial and neuronal migration by lipocalin-2 in zebrafish. Immune Netw. 2011, 11, 342-347.
147. Lee, S., Lee, W. H., Lee, M. S., Mori, K., Suk, K., Regulation by lipocalin-2 of neuronal cell death, migration, and morphology. J. Neurosci. Res. 2012, 90, 540-550.
148. Lee, S., Kim, J. H., Seo, J. W., Han, H. S. et al., Lipocalin-2 Is a chemokine inducer in the central nervous system: role of chemokine ligand 10 (CXCL10) in lipocalin-2-induced cell migration. J. Biol. Chem. 2011, 286, 43855-43870.
149. Rathore, K. I., Berard, J. L., Redensek, A., Chierzi, S. et al., Lipocalin 2 plays an immunomodulatory role and has detrimental effects after spinal cord injury. J. Neurosci. 2011, 31, 13412-13419.
150. Lee, S., Park, J. Y., Lee, W. H., Kim, H. et al., Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J. Neurosci. 2009, 29, 234-249.
151. Lee, S., Lee, J., Kim, S., Park, J. Y. et al., A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J. Immunol. 2007, 179, 3231-3241.
152. Nave, K. A., Myelination and support of axonal integrity by glia. Nature 2010, 468, 244-252.
153. Trapp, B. D., Nave, K. A., Multiple sclerosis: an immune or neurodegenerative disorder? Annu. Rev. Neurosci. 2008, 31, 247-269.
154. Hanash, S. M., Strahler, J. R., Neel, J. V., Hailat, N. et al., Highly resolving two-dimensional gels for protein sequencing. Proc. Natl. Acad. Sci. U S A 1991, 88, 5709-5713.
155. Ishii, A., Dutta, R., Wark, G. M., Hwang, S. I. et al., Human myelin proteome and comparative analysis with mouse myelin. Proc. Natl. Acad. Sci. U S A 2009, 106, 14605-14610.
156. Robotti, A., Natale, M., Albo, A. G., Lis, K. et al., Acute-phase proteins investigation based on lectins affinity capture prior to 2-DE separation: application to serum from multiple sclerosis patients. Electrophoresis 2010, 31, 2882-2893.
157. Nair, S., Xavier, T., Kumar, M. K., Saha, S., Menon, K. N., Exploitation of detergent thermodynamics in the direct solubilization of myelin membrane proteins for two-dimensional gel electrophoresis for proteomic analysis. Electrophoresis 2011, 32, 3621-3629.
158. Yamaguchi, Y., Miyagi, Y., Baba, H., Two-dimensional electrophoresis with cationic detergents, a powerful tool for the proteomic analysis of myelin proteins. Part 1: technical aspects of electrophoresis. J. Neurosci. Res. 2008, 86, 755-765.
159. Yamaguchi, Y., Miyagi, Y., Baba, H., Two-dimensional electrophoresis with cationic detergents: a powerful tool for the proteomic analysis of myelin proteins. Part 2: analytical aspects. J. Neurosci. Res. 2008, 86, 766-775.
160. Jahn, O., Tenzer, S., Werner, H. B., Myelin proteomics: molecular anatomy of an insulating sheath. Mol. Neurobiol. 2009, 40, 55-72.
161. Vanrobaeys, F., Van Coster, R., Dhondt, G., Devreese, B., Van Beeumen, J., Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry. J. Proteome Res. 2005, 4, 2283-2293.
162. Ly, L., Barnett, M. H., Zheng, Y. Z., Gulati, T. et al., Comprehensive tissue processing strategy for quantitative proteomics of formalin-fixed multiple sclerosis lesions. J. Proteome Res. 2011, 10, 4855-4868.
163. Menon, K. N., Steer, D. L., Short, M., Petratos, S. et al., A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases. Mol. Cell Proteomics 2011, 10, 42:1-14.
164. Stoop, M. P., Singh, V., Dekker, L. J., Titulaer, M. K. et al., Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis. PLoS One 2010, 5, e12442.
165. Qin, Z., Qin, Y., Liu, S., Alteration of DBP levels in CSF of patients with MS by proteomics analysis. Cell. Mol. Neurobiol. 2009, 29, 203-210.
166. Dhaunchak, A. S., Becker, C., Schulman, H., De Faria, O., Jr. et al., Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis. Ann. Neurol. 2012, 71, 601-613.
167. Bernstein, H. G., Steiner, J., Bogerts, B., Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy. Expert Rev. Neurother. 2009, 9, 1059-1071.
168. Martins-de-Souza, D., Lebar, M., Turck, C. W., Proteome analyses of cultured astrocytes treated with MK-801 and clozapine: similarities with schizophrenia. Eur. Arch. Psychiatr. Clin. Neurosci. 2011, 261, 217-228.
169. Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Maccarrone, G. et al., Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J. Psychiatr. Res. 2009, 43, 978-986.
170. Bringmann, A., Pannicke, T., Grosche, J., Francke, M. et al., Muller cells in the healthy and diseased retina. Prog. Retin Eye. Res. 2006, 25, 397-424.
171. Bernardos, R. L., Barthel, L. K., Meyers, J. R., Raymond, P. A., Late-stage neuronal progenitors in the retina are radial Muller glia that function as retinal stem cells. J. Neurosci. 2007, 27, 7028-7040.
172. Merl, J., Ueffing, M., Hauck, S. M., von Toerne, C., Direct comparison of MS-based label-free and SILAC quantitative proteome profiling strategies in primary retinal Muller cells. Proteomics 2012, 12, 1902-1911.
173. Hauck, S. M., Suppmann, S., Ueffing, M., Proteomic profiling of primary retinal Muller glia cells reveals a shift in expression patterns upon adaptation to in vitro conditions. Glia 2003, 44, 251-263.
174. Wyss-Coray, T., Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's. Curr. Alzheimer Res. 2006, 3, 191-195.
175. Yasojima, K., Schwab, C., McGeer, E. G., McGeer, P. L., Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res. 2000, 887, 80-89.
176. Moses, G. S., Jensen, M. D., Lue, L. F., Walker, D. G. et al., Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. J. Neuroinflammation 2006, 3, 28.
177. Chalbot, S., Zetterberg, H., Blennow, K., Fladby, T. et al., Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease. Clin. Chem. 2009, 55, 2171-2179.
178. Martin, R., Cordova, C., Nieto, M. L., Secreted phospholipase A2-IIA-induced a phenotype of activated microglia in BV-2 cells requires epidermal growth factor receptor transactivation and proHB-EGF shedding. J. Neuroinflammation 2012, 9, 154.
179. Mosser, D. M., Edwards, J. P., Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8, 958-969.
180. Gordon, S., Martinez, F. O., Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32, 593-604.
181. Jimenez, S., Baglietto-Vargas, D., Caballero, C., Moreno-Gonzalez, I. et al., Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic. J. Neurosci. 2008, 28, 11650-11661.
182. Colton, C. A., Mott, R. T., Sharpe, H., Xu, Q. et al., Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J. Neuroinflammation 2006, 3, 27.
183. Cameron, B., Tse, W., Lamb, R., Li, X. et al., Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease. J. Neurosci. 2012, 32, 15112-15123.
184. Baker, B. J., Akhtar, L. N., Benveniste, E. N., SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol. 2009, 30, 392-400.
185. Lund, S., Christensen, K. V., Hedtjarn, M., Mortensen, A. L. et al., The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions. J. Neuroimmunol. 2006, 180, 71-87.
186. Mantovani, A., Sica, A., Sozzani, S., Allavena, P. et al., The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25, 677-686.
187. Qin, H., Wilson, C. A., Roberts, K. L., Baker, B. J. et al., IL-10 inhibits lipopolysaccharide-induced CD40 gene expression through induction of suppressor of cytokine signaling-3. J. Immunol. 2006, 177, 7761-7771.
188. Villeda, S. A., Luo, J., Mosher, K. I., Zou, B. et al., The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 2011, 477, 90-94.
189. McGeer, E. G., McGeer, P. L., Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. J. Alzheimers Dis. 2010, 19, 355-361.
190. Ishii, T., Haga, S., Complements, microglial cells and amyloid fibril formation. Res. Immunol. 1992, 143, 614-616.
191. Wegiel, J., Wisniewski, H. M., The complex of microglial cells and amyloid star in three-dimensional reconstruction. Acta. Neuropathol. 1990, 81, 116-124.
192. Wisniewski, H. M., Wegiel, J., Spatial relationships between astrocytes and classical plaque components. Neurobiol. Aging 1991, 12, 593-600.
193. Kadir, A., Marutle, A., Gonzalez, D., Scholl, M. et al., Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease. Brain 2011, 134, 301-317.
194. Okello, A., Edison, P., Archer, H. A., Turkheimer, F. E. et al., Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology 2009, 72, 56-62.
195. Sosunov, A. A., Guilfoyle, E., Wu, X., McKhann, G. M., 2nd, Goldman, J. E., Phenotypic conversions of "protoplasmic" to "reactive" astrocytes in alexander disease. J. Neurosci. 2013, 33, 7439-7450.
196. Messing, A., Brenner, M., Feany, M. B., Nedergaard, M., Goldman, J. E., Alexander disease. J. Neurosci. 2012, 32, 5017-5023.
197. Blanco, A. M., Guerri, C., Ethanol intake enhances inflammatory mediators in brain: role of glial cells and TLR4/IL-1RI receptors. Front Biosci. 2007, 12, 2616-2630.
198. Crews, F. T., Nixon, K., Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol Alcohol. 2009, 44, 115-127.
199. McDonough, K. H., Antioxidant nutrients and alcohol. Toxicology 2003, 189, 89-97.
200. Qin, L., Crews, F. T., Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration. J. Neuroinflammation 2012, 9, 130.
201. Bell-Temin, H., Zhang, P., Chaput, D., King, M. A. et al., Quantitative proteomic characterization of ethanol-responsive pathways in rat microglial cells. J. Proteome Res. 2013, 12, 2067-2077.
202. Jourdain, P., Bergersen, L. H., Bhaukaurally, K., Bezzi, P. et al., Glutamate exocytosis from astrocytes controls synaptic strength. Nat. Neurosci. 2007, 10, 331-339.
203. Rossi, D., Volterra, A., Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res. Bull. 2009, 80, 224-232.
204. Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., Gage, F. H., Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140, 918-934.
205. Garden, G. A., La Spada, A. R., Intercellular (mis)communication in neurodegenerative disease. Neuron 2012, 73, 886-901.
206. Yin, P., Knolhoff, A. M., Rosenberg, H. J., Millet, L. J. et al., Peptidomic analyses of mouse astrocytic cell lines and rat primary cultured astrocytes. J. Proteome Res. 2012, 11, 3965-3973.
207. Nimmerjahn, A., Kirchhoff, F., Helmchen, F., Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308, 1314-1318.
208. Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S., Nabekura, J., Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 2009, 29, 3974-3980.
209. Tremblay, M. E., Lowery, R. L., Majewska, A. K., Microglial interactions with synapses are modulated by visual experience. PLoS Biol 2010, 8, e1000527.
210. Pocock, J. M., Kettenmann, H., Neurotransmitter receptors on microglia. Trends Neurosci. 2007, 30, 527-535.
211. Bezzi, P., Domercq, M., Brambilla, L., Galli, R. et al., CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 2001, 4, 702-710.
212. Nobuta, H., Ghiani, C. A., Paez, P. M., Spreuer, V. et al., STAT3-mediated astrogliosis protects myelin development in neonatal brain injury. Ann. Neurol. 2012, 72, 750-765.
213. Fu, K. Y., Tan, Y. H., Sung, B., Mao, J., Peripheral formalin injection induces unique spinal cord microglial phenotypic changes. Neurosci. Lett. 2009, 449, 234-239.
214. Cao, T., Thomas, T. C., Ziebell, J. M., Pauly, J. R., Lifshitz, J., Morphological and genetic activation of microglia after diffuse traumatic brain injury in the rat. Neuroscience 2012, 225, 65-75.
215. Hjorth, E., Zhu, M., Toro, V. C., Vedin, I. et al., Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-beta42 by human microglia and decrease inflammatory markers. J. Alzheimers Dis. 2013, 35, 697-713.
216. Chhor, V., Le Charpentier, T., Lebon, S., Ore, M. V. et al., Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav. Immun. 2013, 32, 70-85.
217. Colton, C., Wilcock, D. M., Assessing activation states in microglia. CNS Neurol. Disord. Drug Targets 2010, 9, 174-191.
218. Hirai, T., Uchida, K., Nakajima, H., Guerrero, A. R. et al., The prevalence and phenotype of activated microglia/macrophages within the spinal cord of the hyperostotic mouse (twy/twy) changes in response to chronic progressive spinal cord compression: implications for human cervical compressive myelopathy. PLoS One 2013, 8, e64528.
219. Liao, B., Zhao, W., Beers, D. R., Henkel, J. S., Appel, S. H., Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp. Neurol. 2012, 237, 147-152.
220. Brown, G. C., Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem. Soc. Trans. 2007, 35, 1119-1121.
221. Benoit, M., Desnues, B., Mege, J. L., Macrophage polarization in bacterial infections. J. Immunol. 2008, 181, 3733-3739.
222. Burton, M. D., Sparkman, N. L., Johnson, R. W., Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior. J. Neuroinflammation 2011, 8, 54.
223. Heinrich, P. C., Behrmann, I., Muller-Newen, G., Schaper, F., Graeve, L., Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 1998, 334(Pt 2), 297-314.
224. Gomi, M., Aoki, T., Takagi, Y., Nishimura, M. et al., Single and local blockade of interleukin-6 signaling promotes neuronal differentiation from transplanted embryonic stem cell-derived neural precursor cells. J. Neurosci. Res. 2011, 89, 1388-1399.
225. Ellert-Miklaszewska, A., Dabrowski, M., Lipko, M., Sliwa, M. et al., Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia. Glia 2013, 61, 1178-1190.
226. Maiorino, C., Khorooshi, R., Ruffini, F., Lobner, M. et al., Lentiviral-mediated administration of IL-25 in the CNS induces alternative activation of microglia. Gene Ther. 2013, 20, 487-496.
227. David, S., Kroner, A., Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 2011, 12, 388-399.
228. Elenkov, I. J., Chrousos, G. P., Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann. N. Y. Acad. Sci. 2002, 966, 290-303.
229. Kettenmann, H., Kirchhoff, F., Verkhratsky, A., Microglia: new roles for the synaptic stripper. Neuron 2013, 77, 10-18.
230. Pelizzoni, I., Zacchetti, D., Campanella, A., Grohovaz, F., Codazzi, F., Iron uptake in quiescent and inflammation-activated astrocytes: a potentially neuroprotective control of iron burden. Biochim. Biophys. Acta. 2013, 1832, 1326-1333.
231. Ren, Z., Chen, X., Yang, J., Kress, B. T. et al., Improved axonal regeneration after spinal cord injury in mice with conditional deletion of ephrin B2 under the GFAP promoter. Neuroscience 2013, 241, 89-99.
232. Quirie, A., Demougeot, C., Bertrand, N., Mossiat, C. et al., Effect of stroke on arginase expression and localization in the rat brain. Eur. J. Neurosci. 2013, 37, 1193-1202.
233. Ramsey, A. J., Milenkovic, M., Oliveira, A. F., Escobedo-Lozoya, Y. et al., Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner. Proc. Natl. Acad. Sci. U S A 2011, 108, 5795-5800.
234. Guingab-Cagmat, J. D., Newsom, K., Vakulenko, A., Cagmat, E. B. et al., In vitro MS-based proteomic analysis and absolute quantification of neuronal-glial injury biomarkers in cell culture system. Electrophoresis 2012, 33, 3786-3797.
235. Bayes, A., Grant, S. G., Neuroproteomics: understanding the molecular organization and complexity of the brain. Nat. Rev. Neurosci. 2009, 10, 635-646.
236. Dalrymple, A., Wild, E. J., Joubert, R., Sathasivam, K. et al., Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates. J. Proteome Res. 2007, 6, 2833-2840.
237. Hye, A., Lynham, S., Thambisetty, M., Causevic, M. et al., Proteome-based plasma biomarkers for Alzheimer's disease. Brain 2006, 129, 3042-3050.
238. Scornavacca, G., Gesuete, R., Orsini, F., Pastorelli, R. et al., Proteomic analysis of mouse brain cortex identifies metabolic down-regulation as a general feature of ischemic pre-conditioning. J. Neurochem. 2012, 122, 1219-1229.
239. Kobeissy, F. H., Guingab-Cagmat, J. D., Razafsha, M., O'Steen, L. et al., Leveraging biomarker platforms and systems biology for rehabilomics and biologics effectiveness research. PM R 2011, 3, S139-S147.
240. Pan, S., Zhu, D., Quinn, J. F., Peskind, E. R. et al., A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Proteomics 2007, 7, 469-473.
241. Suk, K., Combined analysis of the glia secretome and the CSF proteome: neuroinflammation and novel biomarkers. Expert Rev. Proteomics 2010, 7, 263-274.
242. Grebe, S. K., Singh, R. J., LC-MS/MS in the clinical laboratory: where to from here? Clin. Biochem. Rev. 2011, 32, 5-31.
243. Rogers, R. S., Dharsee, M., Ackloo, S., Sivak, J. M., Flanagan, J. G., Proteomics analyses of human optic nerve head astrocytes following biomechanical strain. Mol. Cell Proteomics 2012, 11, 12302:1-17.
244. Kuramitsu, Y., Miyamoto, H., Tanaka, T., Zhang, X. et al., Proteomic differential display analysis identified upregulated astrocytic phosphoprotein PEA-15 in human malignant pleural mesothelioma cell lines. Proteomics 2009, 9, 5078-5089.
245. Lubieniecka, J. M., Streijger, F., Lee, J. H., Stoynov, N. et al., Biomarkers for severity of spinal cord injury in the cerebrospinal fluid of rats. PLoS One 2011, 6, e19247.
246. Maccarrone, G., Milfay, D., Birg, I., Rosenhagen, M. et al., Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry. Electrophoresis 2004, 25, 2402-2412.
247. Waller, L. N., Shores, K., Knapp, D. R., Shotgun proteomic analysis of cerebrospinal fluid using off-gel electrophoresis as the first-dimension separation. J. Proteome Res. 2008, 7, 4577-4584.
248. Tumani, H., Lehmensiek, V., Lehnert, S., Otto, M., Brettschneider, J., 2D DIGE of the cerebrospinal fluid proteome in neurological diseases. Expert Rev. Proteomics 2010, 7, 29-38.
249. Yin, G. N., Lee, H. W., Cho, J. Y., Suk, K., Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases. Brain Res. 2009, 1265, 158-170.
250. Bernhart, E., Kollroser, M., Rechberger, G., Reicher, H. et al., Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture. Proteomics 2010, 10, 141-158.
251. Yang, F., Shen, Y., Camp, D. G., 2nd, Smith, R. D., High-pH reversed-phase chromatography with fraction concatenation for 2D proteomic analysis. Expert Rev. Proteomics 2012, 9, 129-134.
252. Bechter, K., Schizophrenia: a mild encephalitis?. Fortschr. Neurol. Psychiatr. 2013, 81, 250-259.
253. Moore, N. H., Costa, L. G., Shaffer, S. A., Goodlett, D. R., Guizzetti, M., Shotgun proteomics implicates extracellular matrix proteins and protease systems in neuronal development induced by astrocyte cholinergic stimulation. J. Neurochem. 2009, 108, 891-908.
254. Keene, S. D., Greco, T. M., Parastatidis, I., Lee, S. H. et al., Mass spectrometric and computational analysis of cytokine-induced alterations in the astrocyte secretome. Proteomics 2009, 9, 768-782.
255. Lafon-Cazal, M., Adjali, O., Galeotti, N., Poncet, J. et al., Proteomic analysis of astrocytic secretion in the mouse. Comparison with the cerebrospinal fluid proteome. J. Biol. Chem. 2003, 278, 24438-24448.
256. Greco, T. M., Seeholzer, S. H., Mak, A., Spruce, L., Ischiropoulos, H., Quantitative mass spectrometry-based proteomics reveals the dynamic range of primary mouse astrocyte protein secretion. J. Proteome Res. 2010, 9, 2764-2774.
257. Vergara, D., Martignago, R., Bonsegna, S., De Nuccio, F. et al., IFN-beta reverses the lipopolysaccharide-induced proteome modifications in treated astrocytes. J. Neuroimmunol. 2010, 221, 115-120.
258. Tezel, G., A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration. Prog. Retin Eye Res. 2013, 35, 18-43.
259. Skalnikova, H., Motlik, J., Gadher, S. J., Kovarova, H., Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines. Proteomics 2011, 11, 691-708.
260. Ribeiro, C. A., Salgado, A. J., Fraga, J. S., Silva, N. A. et al., The secretome of bone marrow mesenchymal stem cells-conditioned media varies with time and drives a distinct effect on mature neurons and glial cells (primary cultures). J. Tissue Eng. Regen. Med. 2011, 5, 668-672.
261. Liu, Y., Teng, X., Yang, X., Song, Q. et al., Shotgun proteomics and network analysis between plasma membrane and extracellular matrix proteins from rat olfactory ensheathing cells. Cell Transplant 2010, 19, 133-146.
262. de Monasterio-Schrader, P., Jahn, O., Tenzer, S., Wichert, S. P. et al., Systematic approaches to central nervous system myelin. Cell Mol. Life Sci. 2012, 69, 2879-2894.
263. Seyfried, N. T., Gozal, Y. M., Donovan, L. E., Herskowitz, J. H. et al., Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards. J. Proteome Res. 2012, 11, 2721-2738.
264. Shen, M., Ji, Y., Zhang, S., Shi, H. et al., A proteome map of primary cultured rat Schwann cells. Proteome Sci. 2012, 10, 20.
265. Kim, S., Ock, J., Kim, A. K., Lee, H. W. et al., Neurotoxicity of microglial cathepsin D revealed by secretome analysis. J. Neurochem. 2007, 103, 2640-2650.
266. Shimabukuro, J., Awata, S., Matsuoka, H., Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients. Psychiatr. Clin. Neurosci. 2005, 59, 274-279.
267. Jeon, H., Kim, J. H., Lee, W. H., Lee, M. S., Suk, K., Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity. J. Neuroinflammation 2012, 9, 149.
268. Kim, J. H., Nam, Y. P., Jeon, S. M., Han, H. S., Suk, K., Amyloid neurotoxicity is attenuated by metallothionein: dual mechanisms at work. J. Neurochem. 2012, 121, 751-762.
269. Choi, J., Lee, H. W., Suk, K., Increased plasma levels of lipocalin 2 in mild cognitive impairment. J. Neurol. Sci. 2011, 305, 28-33.
270. Bajo-Graneras, R., Ganfornina, M. D., Martin-Tejedor, E., Sanchez, D., Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat-challenged dopaminergic systems. Glia 2011, 59, 1551-1566.
271. Bajo-Graneras, R., Sanchez, D., Gutierrez, G., Gonzalez, C. et al., Apolipoprotein D alters the early transcriptional response to oxidative stress in the adult cerebellum. J. Neurochem. 2011, 117, 949-960.
272. Ganfornina, M. D., Do Carmo, S., Martinez, E., Tolivia, J. et al., ApoD, a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury. Glia 2010, 58, 1320-1334.